search
Back to results

A Study to Evaluate the Effects of Manidipine Versus Amlodipine and the Combination of Manidipine Plus Delapril Versus Amlodipine Plus Delapril on Intraglomerular Pressure in Hypertensive Patients

Primary Purpose

Hypertension

Status
Completed
Phase
Phase 3
Locations
Germany
Study Type
Interventional
Intervention
amlodipine 10 mg
manidipine 20 mg
amlodipine 5 mg + delapril 30 mg
manidipine 10 mg + delapril 30 mg
Sponsored by
University of Erlangen-Nürnberg Medical School
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hypertension focused on measuring hypertension, intraglomerular pressure

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • male or female patients aged 18 years or older
  • mild to moderate hypertension (systolic blood pressure > 139 mmHg or diastolic blood pressure > 89 mmHg)

Exclusion Criteria:

  • secondary form of arterial hypertension
  • severe hypertension (systolic blood pressure > 179 mmHg or diastolic blood pressure > 109 mmHg)
  • pregnant or lactating women

Sites / Locations

  • Clinical Research Center, Department of Nephrology and Hypertension, University of Erlangen-Nurnberg

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

amlodipine 10 mg

manidipine 20 mg

Arm Description

Outcomes

Primary Outcome Measures

effect of manidipine 20 mg once daily compared to amlodipine 10 mg once daily on intraglomerular pressure

Secondary Outcome Measures

effects of combination of manidipine 10 mg plus delapril 30 mg once daily compared with once daily amlodipine 5 mg plus delapril 30 mg on intraglomerular pressure

Full Information

First Posted
February 24, 2008
Last Updated
January 18, 2013
Sponsor
University of Erlangen-Nürnberg Medical School
Collaborators
Chiesi Farmaceutici S.p.A.
search

1. Study Identification

Unique Protocol Identification Number
NCT00627952
Brief Title
A Study to Evaluate the Effects of Manidipine Versus Amlodipine and the Combination of Manidipine Plus Delapril Versus Amlodipine Plus Delapril on Intraglomerular Pressure in Hypertensive Patients
Official Title
Double Blind, Randomized, Parallel Group, Multicentre Study to Evaluate the Effects of Manidipine 20 MG Vs. Amlodipine 10 MG and the Combination of Manidipine 10 MG Plus Delapril 30 MG Vs. Amlodipine 5 MG Plus Delapril 30 MG on Intraglomerular Pressure in Hypertensive Patients
Study Type
Interventional

2. Study Status

Record Verification Date
January 2013
Overall Recruitment Status
Completed
Study Start Date
November 2007 (undefined)
Primary Completion Date
December 2008 (Actual)
Study Completion Date
December 2008 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Erlangen-Nürnberg Medical School
Collaborators
Chiesi Farmaceutici S.p.A.

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Eight-week multi-national, multicenter, randomized, double blind, active control, two arms, parallel groups study with a 4-week single drug treatment (manidipine or amlodipine) phase followed by a 4-week combination treatment (manidipine + delapril or amlodipine + delapril) phase.
Detailed Description
The aim of the current study is to assess the effect of a 4-week single drug treatment with manidipine or amlodipine and a 4-week combination treatment with manidipine plus delapril or amlodipine plus delapril on intraglomerular pressure in subjects with hypertension.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension
Keywords
hypertension, intraglomerular pressure

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
100 (Actual)

8. Arms, Groups, and Interventions

Arm Title
amlodipine 10 mg
Arm Type
Active Comparator
Arm Title
manidipine 20 mg
Arm Type
Active Comparator
Intervention Type
Drug
Intervention Name(s)
amlodipine 10 mg
Intervention Description
amlodipine 10 mg once daily
Intervention Type
Drug
Intervention Name(s)
manidipine 20 mg
Intervention Description
manidipine 20 mg once daily
Intervention Type
Drug
Intervention Name(s)
amlodipine 5 mg + delapril 30 mg
Intervention Description
amlodipine 5 mg + delapril 30 mg once daily
Intervention Type
Drug
Intervention Name(s)
manidipine 10 mg + delapril 30 mg
Intervention Description
manidipine 10 mg + delapril 30 mg once daily
Primary Outcome Measure Information:
Title
effect of manidipine 20 mg once daily compared to amlodipine 10 mg once daily on intraglomerular pressure
Time Frame
4 weeks
Secondary Outcome Measure Information:
Title
effects of combination of manidipine 10 mg plus delapril 30 mg once daily compared with once daily amlodipine 5 mg plus delapril 30 mg on intraglomerular pressure
Time Frame
4 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: male or female patients aged 18 years or older mild to moderate hypertension (systolic blood pressure > 139 mmHg or diastolic blood pressure > 89 mmHg) Exclusion Criteria: secondary form of arterial hypertension severe hypertension (systolic blood pressure > 179 mmHg or diastolic blood pressure > 109 mmHg) pregnant or lactating women
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Roland E Schmieder, Professor
Organizational Affiliation
University of Erlangen-Nürnberg
Official's Role
Principal Investigator
Facility Information:
Facility Name
Clinical Research Center, Department of Nephrology and Hypertension, University of Erlangen-Nurnberg
City
Erlangen
State/Province
Bavaria
ZIP/Postal Code
91054
Country
Germany

12. IPD Sharing Statement

Citations:
PubMed Identifier
29268712
Citation
Bosch AJ, Harazny JM, Kistner I, Friedrich S, Wojtkiewicz J, Schmieder RE. Retinal capillary rarefaction in patients with untreated mild-moderate hypertension. BMC Cardiovasc Disord. 2017 Dec 21;17(1):300. doi: 10.1186/s12872-017-0732-x.
Results Reference
derived

Learn more about this trial

A Study to Evaluate the Effects of Manidipine Versus Amlodipine and the Combination of Manidipine Plus Delapril Versus Amlodipine Plus Delapril on Intraglomerular Pressure in Hypertensive Patients

We'll reach out to this number within 24 hrs